Study of IBI323 in Patients With Advanced Malignancies

Clinical trial NCT04916119 · UNKNOWN

Trial details

NCT number: NCT04916119
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2021-06-29
Primary completion: 2023-06-23
Enrollment: 322

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.